Global Whole Exome Sequencing Market 2023
According to the latest estimates, the global whole exome sequencing market is predicted to be growing at a CAGR of over 14.2% from 2023 to 2029. The top market companies…
DNA sequencing is a laboratory technique used to determine the exact sequence of bases (A, C, G, and T) in a DNA molecule. The DNA base sequence carries the information a cell needs to assemble protein and RNA molecules. DNA sequence information is important to scientists investigating the functions of genes. The global DNA sequencing market size is projected to grow by USD 29 billion from 2022 to 2028, registering a CAGR of 18.1 percent, according to a new report by Gen Consulting Company.
The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global DNA sequencing market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the DNA sequencing industry.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, sequencing type, application, and region. The global market for DNA sequencing can be segmented by product: sequencing services, sequencing instruments, sequencing consumables, sequencing informatics. Sequencing services was the highest contributor to the global DNA sequencing market. Going forward, the sequencing informatics segment is projected to witness the highest CAGR during the forecast period. DNA sequencing market is further segmented by sequencing type: next generation sequencing (NGS), sanger sequencing, others. Globally, the NGS segment made up the largest share of the DNA sequencing market. Based on application, the DNA sequencing market is segmented into: applied, clinical, research. On the basis of region, the DNA sequencing market also can be divided into: Asia Pacific, Europe, North America, Rest of the World (RoW). North America is estimated to account for the largest share of the global DNA sequencing market.
By product:
– sequencing services
– sequencing instruments
– sequencing consumables
– sequencing informatics
By sequencing type:
– next generation sequencing (NGS)
– sanger sequencing
– others
By application:
– applied
– clinical
– research
By region:
– Asia Pacific
– Europe
– North America
– Rest of the World (RoW)
The global DNA sequencing market report offers detailed information on several market vendors, including Adaptive Biotechnologies Corp., Agilent Technologies, Inc., Ambry Genetics Corporation, BD (Becton, Dickinson and Company), Berry Genomics Co., Ltd., BGI Group, Biodesix, Inc., CareDx, Inc., Centogene AG, Danaher Corporation, Devyser Diagnostics AB, Illumina, Inc., Macrogen, Inc., Merck KGaA, myDNA Inc., Natera, Inc., NeoGenomics Laboratories, Inc., New England Biolabs, Inc., NGeneBio Co., Ltd., Oxford Nanopore Technologies Limited, Pacific Biosciences of California, Inc., PerkinElmer, Inc., Personalis, Inc., Qiagen N.V., Quest Diagnostics Inc., Roche Holding AG, SOPHiA GENETICS, TAKARA BIO INC., Thermo Fisher Scientific Inc., among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.
Scope of the Report
– To analyze and forecast the market size of the global DNA sequencing market.
– To classify and forecast the global DNA sequencing market based on product, sequencing type, application, region.
– To identify drivers and challenges for the global DNA sequencing market.
– To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global DNA sequencing market.
– To identify and analyze the profile of leading players operating in the global DNA sequencing market.
Why Choose This Report
– Gain a reliable outlook of the global DNA sequencing market forecasts from 2022 to 2028 across scenarios.
– Identify growth segments for investment.
– Stay ahead of competitors through company profiles and market data.
– The market estimate for ease of analysis across scenarios in Excel format.
– Strategy consulting and research support for three months.
– Print authentication provided for the single-user license.
TABLE OF CONTENTS
FIGURES AND TABLES
PART 1. INTRODUCTION
· Report description
· Objectives of the study
· Market segment
· Years considered for the report
· Currency
· Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
· Introduction
· Drivers
· Restraints
· Impact of COVID-19 pandemic
PART 5. MARKET BREAKDOWN BY PRODUCT
· Sequencing services
· Sequencing instruments
· Sequencing consumables
· Sequencing informatics
PART 6. MARKET BREAKDOWN BY SEQUENCING TYPE
· Next generation sequencing (NGS)
· Sanger sequencing
· Others
PART 7. MARKET BREAKDOWN BY APPLICATION
· Applied
· Clinical
· Research
PART 8. MARKET BREAKDOWN BY REGION
· Asia Pacific
· Europe
· North America
· Rest of the World (RoW)
PART 9. KEY COMPANIES
· Adaptive Biotechnologies Corp.
· Agilent Technologies, Inc.
· Ambry Genetics Corporation
· BD (Becton, Dickinson and Company)
· Berry Genomics Co., Ltd.
· BGI Group
· Biodesix, Inc.
· CareDx, Inc.
· Centogene AG
· Danaher Corporation
· Devyser Diagnostics AB
· Illumina, Inc.
· Macrogen, Inc.
· Merck KGaA
· myDNA Inc.
· Natera, Inc.
· NeoGenomics Laboratories, Inc.
· New England Biolabs, Inc.
· NGeneBio Co., Ltd.
· Oxford Nanopore Technologies Limited
· Pacific Biosciences of California, Inc.
· PerkinElmer, Inc.
· Personalis, Inc.
· Qiagen N.V.
· Quest Diagnostics Inc.
· Roche Holding AG
· SOPHiA GENETICS
· TAKARA BIO INC.
· Thermo Fisher Scientific Inc.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER
Adaptive Biotechnologies Corp.
Agilent Technologies, Inc.
Ambry Genetics Corporation
BD (Becton, Dickinson and Company)
Berry Genomics Co., Ltd.
BGI Group
Biodesix, Inc.
CareDx, Inc.
Centogene AG
Danaher Corporation
Devyser Diagnostics AB
Illumina, Inc.
Macrogen, Inc.
Merck KGaA
myDNA Inc.
Natera, Inc.
NeoGenomics Laboratories, Inc.
New England Biolabs, Inc.
NGeneBio Co., Ltd.
Oxford Nanopore Technologies Limited
Pacific Biosciences of California, Inc.
PerkinElmer, Inc.
Personalis, Inc.
Qiagen N.V.
Quest Diagnostics Inc.
Roche Holding AG
SOPHiA GENETICS
TAKARA BIO INC.
Thermo Fisher Scientific Inc.
REPORT ATTRIBUTE | DETAILS |
---|---|
Base Year | 2021 |
Forecast Year | 2022-2028 |
CAGR (2022-2028) | 18.1% |
Pages | 93 |
Key Players | Adaptive Biotechnologies Corp., Agilent Technologies Inc., Ambry Genetics Corporation, BD (Becton Dickinson and Company), Berry Genomics Co. Ltd., BGI Group, Biodesix Inc., CareDx Inc., Centogene AG, Danaher Corporation, Devyser Diagnostics AB, Illumina Inc., Macrogen Inc., Merck KGaA, myDNA Inc., Natera Inc., NeoGenomics Laboratories Inc., New England Biolabs Inc., NGeneBio Co. Ltd., Oxford Nanopore Technologies Limited, Pacific Biosciences of California Inc., PerkinElmer Inc., Personalis Inc., Qiagen N.V., Quest Diagnostics Inc., Roche Holding AG, SOPHiA GENETICS, TAKARA BIO INC., Thermo Fisher Scientific Inc. |
According to the latest estimates, the global whole exome sequencing market is predicted to be growing at a CAGR of over 14.2% from 2023 to 2029. The top market companies…
The global continuous bioprocessing market, in terms of revenue, is expected to grow by 17.9 percent annually through 2029, according to the latest estimates. The top market companies profiles included…
The global virology testing market is projected to expand at a CAGR of ~1.2 percent across the forecast period of 2023 – 2029, according to the latest edition of the…
Please fill out our form and we will get back to you.